CIPLA
Quarterly Results Analysis [Sep2023]
CIPLA Quarterly Results
Consolidated | Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
Mar2022 Audited |
Dec2021 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹6,678 Cr | ₹6,329 Cr | ₹5,739 Cr | ₹5,810 Cr | ₹5,829 Cr | ₹5,375 Cr | ₹5,260 Cr | ₹5,479 Cr |
Expenses | ₹4,944 Cr | ₹4,835 Cr | ₹4,566 Cr | ₹4,403 Cr | ₹4,526 Cr | ₹4,232 Cr | ₹4,511 Cr | ₹4,248 Cr |
Operating Income | ₹1,734 Cr | ₹1,494 Cr | ₹1,174 Cr | ₹1,408 Cr | ₹1,302 Cr | ₹1,143 Cr | ₹750 Cr | ₹1,231 Cr |
Other Income | ₹176 Cr | ₹136 Cr | ₹135 Cr | ₹114 Cr | ₹123 Cr | ₹103 Cr | ₹64 Cr | ₹91 Cr |
Interest | ₹26 Cr | ₹16 Cr | ₹34 Cr | ₹32 Cr | ₹26 Cr | ₹18 Cr | ₹18 Cr | ₹21 Cr |
Depreciation | ₹290 Cr | ₹239 Cr | ₹346 Cr | ₹272 Cr | ₹299 Cr | ₹254 Cr | ₹290 Cr | ₹247 Cr |
Profit Before Tax | ₹1,594 Cr | ₹1,375 Cr | ₹745 Cr | ₹1,218 Cr | ₹1,100 Cr | ₹975 Cr | ₹448 Cr | ₹1,054 Cr |
Profit After Tax | ₹1,156 Cr | ₹997 Cr | ₹523 Cr | ₹808 Cr | ₹798 Cr | ₹707 Cr | ₹377 Cr | ₹759 Cr |
EPS | ₹14.01 | ₹12.33 | ₹6.51 | ₹9.92 | ₹9.78 | ₹8.51 | ₹4.49 | ₹9.03 |
Industry Peers & Returns | 1W | 1M | 1Y |
CIPLA | -0.5% | 0.1% | 8.9% |
SUN PHARMACEUTICAL INDUSTRIES | 1% | 7.9% | 18.5% |
DIVIS LABORATORIES | -1.4% | 6.6% | 9.4% |
DR REDDYS LABORATORIES | -1% | 7.3% | 29.2% |
TORRENT PHARMACEUTICALS | -2.3% | 5.9% | 27.9% |
ABBOTT INDIA | -2.9% | -0.9% | 12.5% |
ZYDUS LIFESCIENCES | -0.4% | 8.7% | 54% |
ALKEM LABORATORIES | 0.1% | 23.7% | 48.7% |
LUPIN | -2.9% | 3.6% | 63.4% |
CIPLA Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 5.52 % |
Y-o-Y | 14.58 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Sep2023 | ₹6,678 Cr | 5.52 | |
Jun2023 | ₹6,329 Cr | 10.27 | |
Mar2023 | ₹5,739 Cr | -1.22 | |
Dec2022 | ₹5,810 Cr | -0.32 | |
Sep2022 | ₹5,829 Cr | 8.43 | |
Jun2022 | ₹5,375 Cr | 2.18 | |
Mar2022 | ₹5,260 Cr | -3.99 | |
Dec2021 | ₹5,479 Cr | - |
CIPLA Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 16.05 % |
Y-o-Y | 33.13 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Sep2023 | ₹1,734 Cr | 16.05 | |
Jun2023 | ₹1,494 Cr | 27.28 | |
Mar2023 | ₹1,174 Cr | -16.61 | |
Dec2022 | ₹1,408 Cr | 8.08 | |
Sep2022 | ₹1,302 Cr | 13.90 | |
Jun2022 | ₹1,143 Cr | 52.50 | |
Mar2022 | ₹750 Cr | -39.10 | |
Dec2021 | ₹1,231 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 10.00 % |
Y-o-Y | 16.20 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Sep2023 | 25.96% | 10.00 | |
Jun2023 | 23.6% | 15.40 | |
Mar2023 | 20.45% | -15.60 | |
Dec2022 | 24.23% | 8.46 | |
Sep2022 | 22.34% | 5.03 | |
Jun2022 | 21.27% | 49.26 | |
Mar2022 | 14.25% | -36.58 | |
Dec2021 | 22.47% | - |
CIPLA Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 15.98 % |
Y-o-Y | 44.88 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Sep2023 | ₹1,156 Cr | 15.98 | |
Jun2023 | ₹997 Cr | 90.51 | |
Mar2023 | ₹523 Cr | -35.26 | |
Dec2022 | ₹808 Cr | 1.29 | |
Sep2022 | ₹798 Cr | 12.91 | |
Jun2022 | ₹707 Cr | 87.56 | |
Mar2022 | ₹377 Cr | -50.36 | |
Dec2021 | ₹759 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 9.90 % |
Y-o-Y | 26.44 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Sep2023 | 17.31 % | 9.90 | |
Jun2023 | 15.75 % | 72.89 | |
Mar2023 | 9.11 % | -34.51 | |
Dec2022 | 13.91 % | 1.61 | |
Sep2022 | 13.69 % | 4.19 | |
Jun2022 | 13.14 % | 83.52 | |
Mar2022 | 7.16 % | -48.30 | |
Dec2021 | 13.85 % | - |
CIPLA Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 13.63 % |
Y-o-Y | 43.25 % |
Quarters | EPS | % Change | |
---|---|---|---|
Sep2023 | ₹14.01 | 13.63 | |
Jun2023 | ₹12.33 | 89.40 | |
Mar2023 | ₹6.51 | -34.38 | |
Dec2022 | ₹9.92 | 1.43 | |
Sep2022 | ₹9.78 | 14.92 | |
Jun2022 | ₹8.51 | 89.53 | |
Mar2022 | ₹4.49 | -50.28 | |
Dec2021 | ₹9.03 | - |
You may also like the below Video Courses
